About me
Tim Kelly is a biotech executive with over 20 years of leadership experience, currently serving as Chief Technology Officer at Caribou Biosciences. Previously, he was CEO of OXB Solutions LLC, where he led the spin-out of a new cell and gene therapy business. He also served as COO at Homology Medicines, overseeing the company’s operations and development of gene therapy and gene editing technologies. With leadership roles at companies like Sarepta, Shire, UCB and Biogen, Kelly has managed both large-scale and start-up operations, product development, and multi-billion-dollar portfolios across technologies.